Dynavax Technologies Corporation (0IDA.L) LSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Dynavax Technologies Corporation
Address
2100 Powell Street
EmeryVille, CA 94608
United States of America (the)
Phone
510 848 5100
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
405
First IPO Date
January 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Ryan Spencer | Chief Executive Officer & Director | 1.48M | 1979 |
| Kelly MacDonald | Senior Vice President & Chief Financial Officer | 733,501 | 1984 |
| John Slebir | Senior Vice President & General Counsel | 809,129 | 1965 |
| Robert Janssen | Chief Medical Officer and Senior Vice President of Clinical Development, Medical & Regulatory Affairs | 827,719 | 1954 |
| David F. Novack | Senior VP & COO | 965,313 | 1962 |
| Eric Frings | Vice President, Site Head & MD for Dynavax GmbH | 0 | N/A |
| Jeff Coon | Senior Vice President & Chief Human Resources Officer | 0 | 1963 |
| Joseph Metzinger | Vice President & Chief Accounting Officer | 0 | 1984 |
| Paul Cox | Vice President of Investor Relations & Corporate Communications | 0 | N/A |
| Donn Casale | Senior Vice President & Chief Commercial Officer | 0 | N/A |
| Dong Yu | Senior Vice President of Research | 0 | N/A |
Description
Dynavax Technologies Corporation operates as a biopharmaceutical firm, primarily dedicated to the research, development, and commercialization of innovative vaccines within the United States. Its leading product is HEPLISAV-B, a hepatitis B vaccine available in both the U.S. and European markets, designed to protect adults aged 18 and above from all known subtypes of the hepatitis B virus. The company also manufactures and provides CpG 1018, an adjuvant critical to the formulation of HEPLISAV-B. Dynavax has established various strategic partnerships, including a collaborative agreement with Valneva Scotland Limited, an understanding with Serum Institute of India Pvt. Ltd., and a sublicense deal with Merck, Sharp & Dohme Corp. Originally incorporated in 1996 under the name Double Helix Corporation, the company rebranded as Dynavax Technologies Corporation in September of that same year, with its corporate headquarters situated in Emeryville, California.
